Markets › United States › NAS › SLGL

Sol-Gel Technologies Ltd

NAS:SLGLHealthcareNASDAQ:NCXnasdaq_composite

$68.86+2.17%LiveIn session · ≈ AED 252.87 · Market cap $225.43M · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	−218.2%	34.8%	−226.6%	−1,414.9%	98.0%	100.0%	—	—
Operating margin	−344.7%	9.5%	−418.3%	−1,885.8%	−104.1%	−38.9%	−38.9%	+0.0 pts
Net margin	−333.9%	10.3%	−384.3%	−1,752.8%	−91.7%	−31.6%	−31.6%	+0.0 pts
EBITDA margin	−333.9%	12.3%	−403.9%	−1,863.8%	−89.7%	−38.3%	—	—
Return on equity	−57.6%	5.8%	−35.4%	−70.5%	−36.7%	−26.9%	−26.9%	+0.0 pts
Return on assets	−49.5%	4.7%	−32.0%	−60.1%	−29.5%	−20.5%	−20.5%	+0.0 pts
Return on capital employed	−56.8%	5.2%	−37.5%	−71.9%	−39.3%	−31.7%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	3.3%	2.3%	1.7%	3.7%	3.6%	3.3%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	9.0×	4.9×	12.9×	9.1×	5.9×	4.4×	4.4×	+0.0%
Quick ratio	9.0×	4.9×	12.9×	9.1×	5.9×	4.4×	—	—
Cash ratio	1.2×	1.7×	3.7×	1.7×	3.7×	1.8×	1.8×	+0.0%
Asset turnover	0.1×	0.5×	0.1×	0.0×	0.3×	0.6×	—	—
Receivables turnover	4.1×	2.4×	0.5×	4.1×	3.2×	9.9×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—